Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02002533 · ClinicalTrials.gov registry record · NA
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
A NA study of Stage II Breast Cancer and Stage IIIA Breast Cancer, sponsored by Gary Morrow.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
- 6
- Study locations
NCT02002533 is a NA study of Stage II Breast Cancer and Stage IIIA Breast Cancer that has completed, run by Gary Morrow. The registered enrollment target is 71 participants, below the 317-participant average among 30 other Stage II Breast Cancer trials with a reported enrollment target (78% lower). The trial reports 6 study locations across 6 states.
The verdict
NCT02002533, a NA study of Stage II Breast Cancer and Stage IIIA Breast Cancer, has completed, sponsored by Gary Morrow.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
- 6
- Study locations
Study Summary
This randomized phase II trial studies how well brief behavioral therapy works in improving sleep disorders in patients with stage I-III breast cancer undergoing chemotherapy. Sleep disorder counseling may reduce fatigue and insomnia as well as improve the well-being and quality of life in patients with breast cancer who are undergoing chemotherapy.
Conditions Studied
Interventions
- OTHER Educational Intervention
- BEHAVIORAL Telephone-Based Intervention
- BEHAVIORAL Brief Behavioral Therapy
Study Locations (6)
California
- Stanford University Medical Center - Stanford
Illinois
- Heartland NCORP - Decatur
Kansas
- Wichita NCORP - Wichita
Minnesota
- Metro-Minnesota NCORP - Minneapolis
New York
- University of Rochester - Rochester
North Carolina
- Southeast Clinical Oncology Research Program - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2014-02-03 |
| Est. Completion | 2016-12-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02002533
The ClinicalTrials.gov registry entry for NCT02002533 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 317-participant average among 30 other Stage II Breast Cancer trials with a reported enrollment target (78% lower). The listed sponsor is Gary Morrow, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Stage II Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which Educational Intervention is the first listed.
NCT02002533 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Illinois, Kansas.
Frequently Asked Questions
What is clinical trial NCT02002533 about?
NCT02002533 is a clinical study titled "Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy". This randomized phase II trial studies how well brief behavioral therapy works in improving sleep disorders in patients with stage I-III breast cancer undergoing chemotherapy. Sleep disorder counseling may reduce fatigue and insomnia as well as improve the well-being and quality of life in patients ...
What is the current status of trial NCT02002533?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2014-02-03. Estimated completion is 2016-12-16.
What conditions does trial NCT02002533 study?
This clinical trial studies the following conditions: Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Sleep Disorder.
What interventions are being tested in trial NCT02002533?
The interventions under investigation include: Educational Intervention (OTHER), Telephone-Based Intervention (BEHAVIORAL), Brief Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02002533?
This trial is sponsored by Gary Morrow, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02002533 being conducted?
This trial has 6 study locations across California, Illinois, Kansas, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage II Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
RECRUITING · NA
-
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
RECRUITING · NA
-
Improving Exercise Capacity With a Tailored Physical Activity Intervention
RECRUITING · NA
-
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
ACTIVE NOT RECRUITING · NA
-
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)
ACTIVE NOT RECRUITING · NA
-
Researching the Effect of Exercise on Cancer
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.